Atlas Trials

Zhimin Shao

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Zhimin Shao

RecordFirmDate
A Phase II, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Neoadjuvant Therapy With Inavolisib Plus Pertuzumab and Trastuzumab as Subcutaneous (PH-FDC SC) and 3-week Cycle Nab-paclitaxel for PIK3CA-mutated, HER2+, eBC (NCT07245797)Zhimin Shao2025-12-15
PARP Inhibitor With CDK4/ 6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer (NCT06612814)Zhimin Shao2024-09-01
Study to Determine the Utility of FES-PET in the Prediction of Response to Fulvestrant in Women With Estrogen Positive Metastatic Breast Cancer (NCT03507088)Zhimin Shao2015-09-01
Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer (NCT01428414)Zhimin Shao2011-08-01

Track Zhimin Shao automatically

Every clearance here is in the API, with alerts when new ones post.